SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Executive Leadership ▸ Pramuch Goel
Pramuch has completed the Global Program for Management Development from the Ross School of Business at the University of Michigan. He holds an MBA from the Birla Institute of Management Technology, New Delhi, and an English (Hons) degree from the University of Delhi. He also possesses certifications in digital marketing and a PGDM in public relations. Pramuch joined Syngene in August 2024 from the Mahindra Group, where he served as vice president and head of group communications. Prior to Mahindra, he has held positions at companies including Samsung India, Cisco Systems, IBM India, and Quark Inc. As a member of the Executive Committee and the ESG Council, his responsibilities encompass Corporate Communications, Public Affairs, and Environment, Social, and Governance (ESG) activities.
© 2025. Syngene International Limited